CRRT在治疗重症急性胰腺炎中的应用

doi:10.3969/j.issn.1000-8535.2022.05.021

摘要/Abstract

摘要： 目的探讨连续性肾脏替代治疗(CRRT)在治疗重症急性胰腺炎(SAP)中的临床意义。方法回顾分析2018年1月—2019年1月在我院接受救治的SAP患者64例,根据治疗方案的不同分为观察组和对照组, 每组各搜集32例,2组患者基线水平一致。对照组为采用常规内科方案治疗的病例, 观察组为对照组治疗方案基础上联合CRRT的病例,分析对比2组治疗后的各项疗效指标。结果 2组患者治疗后5~7 d内APACHE Ⅱ评分[(11.02±3.14)vs(13.98±3.27)分]、甘油三脂[(4.02±1.05)vs(5.62±1.11)mmol/L]、C反应蛋白[(88.25±6.73)vs(104.41±10.28)ng/L]、降钙素原[(13.12±4.33)vs(18.55±3.96)ng/mL、血尿素氮[(7.33±1.72) vs (11.24±2.76) mmol/L]、血肌酐[(69.51±15.03) vs(91.12±19.17)mmol/L]相较治疗前均降低,观察组患者上述指标水平下降幅度超过对照组,结果分析差异有统计学意义(t=3.693, 5.924, 7.440, 9.362, 5.235, 6.801, 5.018,P均＜0.001)。观察组患者治疗期间疾病症状缓解时间[(3.15±1.26)vs (5.22±1.51) d]、体征指标稳定时间[(2.52±1.38) vs (4.39±1.50) d]、胃肠功能恢复时间[(4.48±1.27) vs (6.21±1.55) d]以及ICU住院时间[(15.03±2.21) vs (18.44±3.27) d]均低于对照组,结果分析差异有统计学意义(t=5.954, 5.190, 4.884,4.888,P均＜0.05)。结论与常规内科治疗相比,联合CRRT治疗SAP能够显著改善各项炎症指标,有助患者快速脱离重症危险状态,具有积极的临床价值。

关键词: 连续性肾脏替代治疗, 重症急性胰腺炎, 炎性指标

Abstract: Objective To explore the clinical significance of continuous renal replacement therapy (CRRT) in the treatment of severe acute pancreatitis (SAP). Methods Retrospective analysis of 64 patients with SAP in our hospital from January 2018 to January 2019 was carried out. The patients were divided into the observation group and the control group according to different treatment regimens, with 32 cases in each group, and the baseline levels of the two groups were consistent. Patients in the control group were treated with conventional medical treatment, and the patients in the observation group were treated with CRRT on the basis of the control group, and the efficacy of the two groups were analyzed and compared. Results The APACHE II scores [(11.02±3.14) vs (13.98±3.27)]、triglyceride[(4.02±1.05) vs (5.62±1.11) mmol/L], C-reactive protein[(88.25±6.73) vs (104.41±10.28) ng/L], procalcitonin[(13.12±4.33) vs (18.55±3.96) ng/mL], blood urea nitrogen[(7.33±1.72) vs (11.24±2.76) mmol/L], serum creatinine[(69.51±15.03)vs(91.12±19.17)mmol/L] of patients in both groups were significantly decreased within 5-7 days after treatment compared with those before treatment, and the decrease of the above indicators in the observation group was significantly greater than that in the control group, P<0.05. The remission time of symptoms[(3.15±1.26) vs (5.22±1.51) d], the stabilization time of signs[(2.52±1.38) vs (4.39±1.50) d], the recovery time of gastrointestinal function[(4.48±1.27) vs (6.21±1.55) d] and the length of ICU stay[(15.03±2.21) vs (18.44±3.27) d] in the observation group were lower than those in the control group, and the analysis of the results was statistically significant (t=5.954, 5.190, 4.884,4.888,all P＜0.05). Conclusions Compared with conventional medical treatment, additional CRRT treatment can significantly improve the inflammatory indicators of SAP, help patients survive from critical state of SAP, which has positive clinical value.

Key words: continuous renal replacement therapy, severe acute pancreatitis, inflammatory markers

陈杰舜, 廖银光. CRRT在治疗重症急性胰腺炎中的应用[J]. 广州医药, 2022, 53(5): 101-104.

CHEN Jieshun, LIAO Yinguang. Application of continuous renal replacement therapy in the treatment of severe acute pancreatitis[J]. Guangzhou Medical Journal, 2022, 53(5): 101-104.

参考文献

[1] 蒋雅丽, 孙云, 王金庆,等. CRRT与血液透析滤过对重症急性胰腺炎的疗效比较[J]. 中国现代普通外科进展, 2019, 22(1):64-67.
[2] 李辉华, 王铮, 黄祥卫,等. 连续性血液净化治疗重症急性胰腺炎合并急性肾损伤疗效观察[J]. 海南医学, 2018, 29(9):1279-1281.
[3] 米芷颉, 龚鸿昌, 俸小飞. 连续肾脏替代疗法对感染性休克致急性肾损伤患者的临床意义[J]. 标记免疫分析与临床, 2018,25(7):1048-1051,1056.
[4] 孙博睿, 张春, 林婷, 等. CRRT对重症急性胰腺炎患者接受经皮引流治疗的影响:一项回顾性队列研究[J]. 中华危重病急救医学, 2019, 31(6):714-718.
[5] 岳鹏, 李国栋, 陈元清. 连续性肾脏替代治疗重症胰腺炎患者结合降钙素原动态监测对临床治疗的指导价值[J]. 河北医药, 2018, 40(24):3737-3740,3744.
[6] 中华医学会外科学分会胰腺外科学组.中国急性胰腺炎诊治指南(2021)[J].中华外科杂志,2021,59(7):578-587.
[7] 蔡世文, 王国平, 党晓燕. 床旁CRRT疗法联合异甘草酸镁注射液对重症急性胰腺炎患者血清ICAM-1,IL-6水平的影响[J]. 中国医师杂志, 2019, 21(9):4.
[8] 刘琰, 陈琴, 袁雪,等. CRRT治疗重症胰腺炎的疗效及对患者胰腺微循环指标和血清Ghrelin PCT水平的影响[J]. 河北医学, 2020, 26(1):67-71.
[9] 樊媛,潘龙飞,牛泽群,等. 乌司他丁联合CRRT对重症急性胰腺炎患者血管内皮功能和血小板活化因子的影响[J].肝胆胰外科杂志, 2020,32(10):605-609.
[10] 张宇艳, 张海蓉, 张景丽,等. 连续性血液净化治疗重症急性胰腺炎的研究进展[J].临床肝胆病杂志, 2020, 36(6):1428-1432.
[11] 潘鹏飞, 李文哲, 杜欣欣,等. 血液净化对脓毒症免疫调理作用的研究进展[J].中国急救医学, 2018,38(3):269-272.
[12] 康利民,潘明新,高毅,等. 肠内免疫微生态营养对重症急性胰腺炎患者免疫功能及治疗效果的影响[J]. 实用医学杂志, 2013(18),3014-3016.
[13] 刘新生, 冯恩志, CRRT在重症胰腺炎治疗中的应用研究[J]. 西北国防医学杂志, 2017, 26(7):460-462.
[14] 蒋骅, 汪小华, 陶春霞,等. 急性胰腺炎患者急性期疼痛现状及其对住院时间的影响[J]. 中国全科医学, 2018, 21(27):3366-3369.
[15] 邵兴.连续性肾脏替代治疗对重症急性胰腺炎患者炎症介质的影响及疗效评价[J].中国现代医生,2016,54(2):16-19,22.
[16] 彭博, 孟德志, 黄秀峰. 连续性肾脏替代疗法治疗重症急性胰腺炎的效果及对炎性介质和凝血功能的影响[J]. 解放军预防医学杂志, 2019, 37(5):51-52.
[17] 孙江利,裴红红,潘龙飞,等. 丙氨酰谷氨酰胺联合乌司他丁对重症急性胰腺炎肺损伤的影响及HMGB1,TLR4的可能作用[J]. 现代消化及介入诊疗, 2020, 25(11):1432-1433.
[18] DOMNICKA P,MADUZAI D,CERANOWICZ P,et al. The interplay between inflammation,coagulation and endothelial injury in the early phase of acute pancreaitis:clinical implications[J].Int J MoI Sci,2017,18(2):345.